drugset / Trial / NCT01981005
A Study of the Elimination, Pharmacokinetics, and Metabolism of RO5424802
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This non-randomized, single group, open-label study will investigate the mass balance, routes of elimination, pharmacokinetics, and metabolism of a single oral dose of RO5424802 and the pharmacokinetics of a 14C-labeled tracer in healthy volunteers
Timeline
- Start
- 2013-11
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alectinib | Small molecule | — | Oral |
Indications
No indication recorded.